United States securities and exchange commission logo

                           December 3, 2021

       Kevin Appelbaum
       Chief Executive Officer
       Better Therapeutics, Inc.
       548 Market Street, #49404
       San Francisco, CA 94104

                                                        Re: Better
Therapeutics, Inc.
Statement on Form S-1
                                                            Filed November 29,
                                                            File No. 333-261383

       Dear Mr. Appelbaum:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Dillon
Hagius at 202-551-7967 with any questions.


                           Division of Corporation Finance

                           Office of Life Sciences
       cc:                                              Arthur R. McGivern